why choose us

First received: July 25, 2022

Clinical Trial: Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

Study Status: Completed

Recruit Status: RECRUITING

Condition: Diabetes Mellitus, Type 1

Study Type: INTERVENTIONAL


Official Title: Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

Brief Summary: The investigators will test the hypothesis that, in adults with type 1 diabetes (T1D), glucagon-like peptide-1 receptor agonism (GLP-1RA, i.e. dulaglutide) and exercise training each enhance insulin-mediated skeletal muscle microvascular perfusion via attenuating endothelial oxidative stress and thereby improving endothelial function.

Read more